Derivados selenados como terapia frente a cáncer, tripanosomas y otras patologías
SECALE
Centro de Investigaciones Biológicas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigaciones Biológicas (5)
2016
-
Design of α-S-Neoglycopeptides Derived from MUC1 with a Flexible and Solvent-Exposed Sugar Moiety
Journal of Organic Chemistry, Vol. 81, Núm. 14, pp. 5929-5941
-
Mucin Architecture behind the Immune Response: Design and Evaluation of an Antitumor Vaccine Derived from an Unnatural MUC1 Fragment
Chemical Science, Vol. 7, Núm. 3, pp. 2294
2015
-
Deciphering the Non-Equivalence of Serine and Threonine O-glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody
Angewandte Chemie International, Vol. 54, Núm. 34, pp. 9830
2014
-
Conformational analysis of peptides and glycopeptides derived from the consensus sequence for β-O-glucosylation
Current Topics in Medicinal Chemistry, Vol. 14, Núm. 23, pp. 2712-2721
-
Serine versus Threonine Glycosylation witha-O-GalNAc: Unexpected Selectivity in Their Molecular Recognition with Lectins
Chemistry - A European Journal, Vol. 20, Núm. 39, pp. 12616-12627